The note's velocity idea says Divi's is positioned to benefit from oral Wegovy-driven peptide API demand and 0% US tariff clarity, expecting 21% earnings CAGR over FY26-28, with CMP Rs 9,540, SL Rs 8,870; it also lists a DIVISLAB 9600 CE buy on long build-up.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
All houses
HDFC Securities
Motilal Oswal
Tata Asset Management
Mirae Asset Sharekhan
India IPO
Jainam
GEPL Capital
Way2Wealth
SBICAP Securities
Angel One
Axis Securities
ICICI Direct Research Retail
Religare
Arete Securities
Formerly known as Way2Wealth
ICICI Direct
Way2Wealth Securities
ICICI Securities
quant Mutual Fund
Kotak Securities
JM Financial
ICICI Securities – Retail
Global Markets by Vested
Ventura Securities
Prabhudas Lilladher
Industrial Asphalts
ITC Hotels
Exterminators PLC
Emkay Global
Private Client Group Research summarized from KIE research report
Kahawatte Plantations PLC
Elara Securities
402 notes from Motilal Oswal · all time
The note says Zydus, with MSN Laboratories, launched the first generic Adempas (Riociguat) in the US across all five strengths, and projects 23.5% YoY revenue growth with 23.2% EBITDA margin; CMP INR 1,160.
Read this note →The note says Endurance acquired 100% of Italy's Fondalpress SpA and parent Anna Milena SpA for EUR 12.34mn, expanding its European aluminium die-casting footprint, with India business expected to grow 25% YoY and consolidated PAT up 8% YoY in 2Q, at a CMP of INR 2,516 implying 22% upside.
Read this note →The note lists Bajaj Finance among stocks showing weakness in the derivatives segment.
Read this note →The note lists TVS Motor among stocks showing weakness in the derivatives segment.
Read this note →The note lists TCS among stocks showing weakness in the derivatives segment.
Read this note →The note lists Apollo Hospital among stocks showing weakness in the derivatives segment.
Read this note →The note lists Ultratech Cement among stocks showing weakness in the derivatives segment.
Read this note →The note lists Jindal Steel among stocks showing weakness in the derivatives segment.
Read this note →The note lists IEX among stocks showing weakness in the derivatives segment.
Read this note →The note lists ITC among stocks showing weakness in the derivatives segment.
Read this note →The note lists KEI among stocks showing weakness in the derivatives segment.
Read this note →The note lists Max Health among stocks showing weakness in the derivatives segment.
Read this note →The note lists Federal Bank among stocks showing weakness in the derivatives segment.
Read this note →The note lists TechM among stocks showing weakness in the derivatives segment.
Read this note →The note lists Bandhan Bank among stocks showing weakness in the derivatives segment.
Read this note →The note lists Phoenix Mills among stocks showing weakness in the derivatives segment.
Read this note →The note lists Sona Coms among stocks showing a positive derivatives setup.
Read this note →The note lists CG Power among stocks showing a positive derivatives setup.
Read this note →The note lists Siemens among stocks showing a positive derivatives setup.
Read this note →The note lists Divis Lab among stocks showing a positive derivatives setup.
Read this note →The note lists Laurus Lab among stocks showing a positive derivatives setup.
Read this note →The note lists Radico among stocks showing a positive derivatives setup.
Read this note →The note lists MCX among stocks showing a positive derivatives setup.
Read this note →The note lists Bhel among stocks showing a positive derivatives setup.
Read this note →